205 related articles for article (PubMed ID: 25714942)
1. Antimalarial NADPH-Consuming Redox-Cyclers As Superior Glucose-6-Phosphate Dehydrogenase Deficiency Copycats.
Bielitza M; Belorgey D; Ehrhardt K; Johann L; Lanfranchi DA; Gallo V; Schwarzer E; Mohring F; Jortzik E; Williams DL; Becker K; Arese P; Elhabiri M; Davioud-Charvet E
Antioxid Redox Signal; 2015 May; 22(15):1337-51. PubMed ID: 25714942
[TBL] [Abstract][Full Text] [Related]
2. Inability to maintain GSH pool in G6PD-deficient red cells causes futile AMPK activation and irreversible metabolic disturbance.
Tang HY; Ho HY; Wu PR; Chen SH; Kuypers FA; Cheng ML; Chiu DT
Antioxid Redox Signal; 2015 Mar; 22(9):744-59. PubMed ID: 25556665
[TBL] [Abstract][Full Text] [Related]
3. Pathways for the reduction of oxidized glutathione in the Plasmodium falciparum-infected erythrocyte: can parasite enzymes replace host red cell glucose-6-phosphate dehydrogenase?
Roth EF; Schulman S; Vanderberg J; Olson J
Blood; 1986 Mar; 67(3):827-30. PubMed ID: 3511989
[TBL] [Abstract][Full Text] [Related]
4. Early phagocytosis of glucose-6-phosphate dehydrogenase (G6PD)-deficient erythrocytes parasitized by Plasmodium falciparum may explain malaria protection in G6PD deficiency.
Cappadoro M; Giribaldi G; O'Brien E; Turrini F; Mannu F; Ulliers D; Simula G; Luzzatto L; Arese P
Blood; 1998 Oct; 92(7):2527-34. PubMed ID: 9746794
[TBL] [Abstract][Full Text] [Related]
5. Redox metabolism in glucose-6-phosphate dehydrogenase deficient erythrocytes and its relation to antimalarial chemotherapy.
Ginsburg H; Golenser J
Parassitologia; 1999 Sep; 41(1-3):309-11. PubMed ID: 10697873
[TBL] [Abstract][Full Text] [Related]
6. 1,4-naphthoquinones and other NADPH-dependent glutathione reductase-catalyzed redox cyclers as antimalarial agents.
Belorgey D; Lanfranchi DA; Davioud-Charvet E
Curr Pharm Des; 2013; 19(14):2512-28. PubMed ID: 23116403
[TBL] [Abstract][Full Text] [Related]
7. The Redox Cycler Plasmodione Is a Fast-Acting Antimalarial Lead Compound with Pronounced Activity against Sexual and Early Asexual Blood-Stage Parasites.
Ehrhardt K; Deregnaucourt C; Goetz AA; Tzanova T; Gallo V; Arese P; Pradines B; Adjalley SH; Bagrel D; Blandin S; Lanzer M; Davioud-Charvet E
Antimicrob Agents Chemother; 2016 Sep; 60(9):5146-58. PubMed ID: 27297478
[TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
9. The effect and mechanism of inhibiting glucose-6-phosphate dehydrogenase activity on the proliferation of Plasmodium falciparum.
Zhang Z; Chen X; Jiang C; Fang Z; Feng Y; Jiang W
Biochim Biophys Acta Mol Cell Res; 2017 May; 1864(5):771-781. PubMed ID: 28214533
[TBL] [Abstract][Full Text] [Related]
10. Plasmodium falciparum: thiol status and growth in normal and glucose-6-phosphate dehydrogenase deficient human erythrocytes.
Miller J; Golenser J; Spira DT; Kosower NS
Exp Parasitol; 1984 Jun; 57(3):239-47. PubMed ID: 6373352
[TBL] [Abstract][Full Text] [Related]
11. Inborn defects in the antioxidant systems of human red blood cells.
van Zwieten R; Verhoeven AJ; Roos D
Free Radic Biol Med; 2014 Feb; 67():377-86. PubMed ID: 24316370
[TBL] [Abstract][Full Text] [Related]
12. Ribose metabolism and nucleic acid synthesis in normal and glucose-6-phosphate dehydrogenase-deficient human erythrocytes infected with Plasmodium falciparum.
Roth EF; Ruprecht RM; Schulman S; Vanderberg J; Olson JA
J Clin Invest; 1986 Apr; 77(4):1129-35. PubMed ID: 2420826
[TBL] [Abstract][Full Text] [Related]
13. Glucose-6-phosphate dehydrogenase of malaria parasite Plasmodium falciparum.
Yoshida A; Roth EF
Blood; 1987 May; 69(5):1528-30. PubMed ID: 3552078
[TBL] [Abstract][Full Text] [Related]
14. Stress response and cytoskeletal proteins involved in erythrocyte membrane remodeling upon Plasmodium falciparum invasion are differentially carbonylated in G6PD A- deficiency.
Méndez D; Linares M; Diez A; Puyet A; Bautista JM
Free Radic Biol Med; 2011 May; 50(10):1305-13. PubMed ID: 21376116
[TBL] [Abstract][Full Text] [Related]
15. Co-ordinated stage-dependent enhancement of Plasmodium falciparum antioxidant enzymes and heat shock protein expression in parasites growing in oxidatively stressed or G6PD-deficient red blood cells.
Akide-Ndunge OB; Tambini E; Giribaldi G; McMillan PJ; Müller S; Arese P; Turrini F
Malar J; 2009 May; 8():113. PubMed ID: 19480682
[TBL] [Abstract][Full Text] [Related]
16. NADPH, not glutathione, status modulates oxidant sensitivity in normal and glucose-6-phosphate dehydrogenase-deficient erythrocytes.
Scott MD; Zuo L; Lubin BH; Chiu DT
Blood; 1991 May; 77(9):2059-64. PubMed ID: 2018843
[TBL] [Abstract][Full Text] [Related]
17. An Optimized Dihydrodibenzothiazepine Lead Compound (SBI-0797750) as a Potent and Selective Inhibitor of Plasmodium falciparum and P. vivax Glucose 6-Phosphate Dehydrogenase 6-Phosphogluconolactonase.
Berneburg I; Peddibhotla S; Heimsch KC; Haeussler K; Maloney P; Gosalia P; Preuss J; Rahbari M; Skorokhod O; Valente E; Ulliers D; Simula LF; Buchholz K; Hedrick MP; Hershberger P; Chung TDY; Jackson MR; Schwarzer E; Rahlfs S; Bode L; Becker K; Pinkerton AB
Antimicrob Agents Chemother; 2022 Apr; 66(4):e0210921. PubMed ID: 35266827
[TBL] [Abstract][Full Text] [Related]
18. A fluorometric assay to determine the protective effect of glucose-6-phosphate dehydrogenase (G6PD) against a Plasmodium spp. infection in females heterozygous for the G6PD gene: proof of concept in Plasmodium falciparum.
Rumaseb A; Marfurt J; Kho S; Kahn M; Price RN; Ley B
BMC Res Notes; 2022 Feb; 15(1):76. PubMed ID: 35193663
[TBL] [Abstract][Full Text] [Related]
19. Enhanced susceptibility of erythrocytes deficient in glucose-6-phosphate dehydrogenase to alloxan/glutathione-induced decrease in red cell deformability.
Liu TZ; Lin TF; Hung IJ; Wei JS; Chiu DT
Life Sci; 1994; 55(3):PL55-60. PubMed ID: 8007756
[TBL] [Abstract][Full Text] [Related]
20. Investigating the mode of action of the redox-active antimalarial drug plasmodione using the yeast model.
Mounkoro P; Michel T; Blandin S; Golinelli-Cohen MP; Davioud-Charvet E; Meunier B
Free Radic Biol Med; 2019 Sep; 141():269-278. PubMed ID: 31238126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
